查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1896150

數位療法市場預測至2032年：按療法類型、部署方式、技術、應用、最終用戶和地區分類的全球分析

Digital Therapeutics Market Forecasts to 2032 - Global Analysis By Treatment Type, Deployment, Technology, Application, End User, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的一項研究，預計到 2025 年，全球數位療法市場規模將達到 66 億美元，到 2032 年將達到 295 億美元，預測期內複合年成長率為 23.8%。

數位療法是基於循證醫學的軟體應用程式，旨在透過臨床檢驗的數位干預措施來預防、管理和治療疾病。它們利用行為科學、認知療法、即時監測和個人化護理管道，從而顯著改善患者的治療效果。數位療法可以補充或取代傳統治療方法，尤其是在慢性病管理、精神健康、代謝失調和神經系統疾病方面。數位療法在監管下運行，並與醫療系統連接，以實現數據驅動的連續性護理和遠距臨床支援。

根據 IQVIA 的數位健康趨勢更新報告，每月使用處方箋級數位療法的患者人數已超過 3.7 億，高於 2020 年的 1.1 億，這表明慢性病管理中已廣泛採用數位療法。

遠端患者管理的日益普及

隨著醫療生態系統向虛擬醫療模式轉型，遠距病患管理的日益普及正在加速對數位療法的需求。慢性病盛行率的上升和遠端醫療平台接受度的提高進一步推動了這一趨勢。能夠實現即時監測、藥物依從性追蹤和行為健康介入的數位工具已被證實具有可衡量的臨床益處。醫療服務提供者正在尋求可擴展且經濟高效的方式來管理大規模的患者群體，而數位療法在支持持續參與、提高治療依從性和改善長期健康結果方面正變得至關重要。

許多地區的報銷範圍有限

許多地區有限的報銷覆蓋範圍仍然是大規模推廣應用的一大障礙，尤其是在軟體治療方法監管管道不完善的地區。支付方往往不願意將數位療法納入可報銷範圍，減緩了其融入主流醫療保健體系的進程。評估標準不統一以及臨床經濟學證據不足進一步加劇了資金籌措決策的複雜性。因此，醫療服務提供者和患者經常需要自付費用，阻礙了數位療法的廣泛應用。在全球報銷框架成熟之前，不同醫療保健體系的市場滲透率可能仍將不平衡。

與個人化照護管道的整合

隨著數位療法擴大利用人工智慧驅動的洞察、行為分析和患者特異性生物標記，與個人化醫療管道的整合具有巨大的發展潛力。在慢性病、代謝性疾病和精神疾病領域，個人化治療方案能夠提高療效、增強病人參與並降低復發率。日益豐富的真實世界數據強化了臨床檢驗，並促進了實證醫療模式的應用。隨著醫療保健向精準醫療發展，能夠提供個人化治療最佳化的數位平台正日益成為實現以患者為中心的干涉措施的關鍵基礎。

資料安全漏洞影響病患信任

由於數位療法高度依賴敏感的行為、臨床和生物識別數據，因此，損害患者信任的數據安全漏洞仍然是一個重大威脅。雲端基礎設施、行動應用程式和API整合中的網路漏洞可能導致個人健康資訊洩露，並削弱用戶信任。不遵守監管規定可能導致處罰和醫療設備認證延遲。除非平台展現出強大的網路安全態勢和透明的資料處理實踐，否則大眾對數位隱私日益嚴格的審查可能會減緩數位療法的廣泛應用。

新冠疫情的影響

新冠疫情顯著加速了數位療法的普及，因為在封鎖期間，醫療系統優先考慮遠距醫療模式。患者更多地使用基於應用程式的干涉措施、數位認知行為療法工具和慢性病追蹤平台，以避免線下就診。臨床檢查也轉向線上形式，這提高了監管機構和醫療服務提供者的接受度。疫情提高了人們對可擴展數位醫療管道的認知，疫情後，隨著混合醫療模式的持續發展，需求依然強勁，這鞏固了數位療法在治療服務中的長期作用。

預計在預測期內，慢性病管理系統細分市場將佔據最大的市場佔有率。

由於糖尿病、心血管疾病、呼吸系統疾病和文明病的盛行率不斷上升，預計慢性病管理系統細分市場將在預測期內佔據最大的市場佔有率。這些平台提供系統化的監測、行為指導和治療強化，進而提升患者的自我管理能力。醫療服務提供者越來越依賴此類系統來減少住院次數、最佳化護理協調並提高治療依從性。經證實的臨床有效性和廣泛的適用性確保了其在數位療法領域的持續領先地位。

預計在預測期內，雲端平台細分市場將實現最高的複合年成長率。

由於其可擴展性、互通性和跨醫療系統無縫資料整合能力，預計在預測期內，雲端平台細分市場將實現最高的成長率。雲端架構支援即時分析、遠端存取和持續的病人參與，同時降低營運成本。它支援多設備同步，並有助於縱向監測和自動化治療協調。隨著對柔軟性、安全且易於部署的數位健康解決方案的需求不斷成長，雲端平台正迅速崛起為成長最快的細分市場。

比最大的地區

預計亞太地區將在整個預測期內保持最大的市場佔有率，這主要得益於不斷擴展的數位醫療計劃、智慧型手機的快速普及以及慢性病負擔的日益加重。中國、印度、日本和韓國等國的政府正在加速推廣遠端醫療計畫和基於應用程式的治療工具。醫療保健的日益數位化、有利於遠端醫療的法規環境以及龐大的患者群體進一步推動了這些技術的普及。所有這些因素鞏固了亞太地區作為數位療法應用領先市場的地位。

最高複合年成長率地區

在預測期內，由於醫保報銷機制的不斷改進、數位療法快速融入臨床工作流程以及強勁的創業投資資金籌措，北美地區預計將實現最高的複合年成長率。領先的數位醫療創新者、支持性的法規結構以及醫療服務提供者與科技公司之間日益緊密的夥伴關係，正在加速數位療法的普及應用。對以結果為導向的醫療保健的日益重視以及遠距遠端醫療干預措施的廣泛接受，進一步鞏固了北美作為成長最快區域市場的地位。

免費客製化服務

購買此報告的客戶可享有以下免費自訂選項之一：

  • 公司概況
    • 最多三家新增市場參與企業進行全面分析
    • 主要參與企業（最多3家公司）的SWOT分析
  • 區域細分
    • 根據客戶要求，提供主要國家的市場規模、估算、預測和複合年成長率（註：可行性需確認）。
  • 競爭基準化分析
    • 從產品系列、地域覆蓋範圍和策略聯盟等方面對主要參與企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 摘要
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 技術分析
  • 應用分析
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球數位療法市場（依治療類型分類）

  • 行為健康計劃
  • 慢性病管理系統
  • 實體復健平台
  • 生活方式和營養干預
  • 神經系統治療方案
  • 藥物濫用/成癮治療

6. 全球數位療法市場（以部署方式分類）

  • 基於雲端的平台
  • 本地部署平台
  • 混合數位治療系統
  • 訂閱式平台
  • 綜合醫院平台

7. 全球數位療法市場（按技術分類）

  • 基於人工智慧的治療平台
  • 行動和應用程式解決方案
  • 穿戴式整合系統
  • 遠端監控技術
  • VR/AR治療平台
  • 數據分析雲端系統

第8章 全球數位療法市場（按應用領域分類）

  • 糖尿病和代謝性疾病
  • 精神疾病
  • 心血管疾病
  • 呼吸系統疾病
  • 疼痛管理
  • 肥胖和文明病

9. 全球數位療法市場（按最終用戶分類）

  • 醫院診所
  • 雇主和企業的健康管理
  • 製藥公司
  • 研究所
  • 其他

第10章：全球數位療法市場（按地區分類）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第12章 企業概況

  • Pear Therapeutics
  • Teladoc Health
  • Propeller Health
  • Omada Health
  • Welldoc
  • Noom
  • Akili Interactive
  • Click Therapeutics
  • Biofourmis
  • Kaia Health
  • Livongo（Teladoc）
  • Mahana Therapeutics
  • Voluntis
  • Happify Health
  • Better Therapeutics
  • Big Health
  • BehaVR
Product Code: SMRC32837

According to Stratistics MRC, the Global Digital Therapeutics Market is accounted for $6.6 billion in 2025 and is expected to reach $29.5 billion by 2032 growing at a CAGR of 23.8% during the forecast period. Digital Therapeutics are evidence-based software applications designed to prevent, manage, or treat medical conditions through clinically validated digital interventions. Using behavioral science, cognitive therapies, real-time monitoring, and personalized treatment pathways, these platforms deliver measurable improvements in patient outcomes. They complement or substitute traditional therapies, especially in chronic disease management, mental health, metabolic disorders, and neurological conditions. Digital therapeutics operate under regulatory oversight and integrate with healthcare systems, ensuring data-driven care continuity and remote clinical support.

According to IQVIA's Digital Health Trends update, over 370 million unique patients now use prescription-grade digital therapeutics monthly, up from 110 million in 2020, signaling widespread clinical adoption for chronic disease management.

Market Dynamics:

Driver:

Growing adoption of remote patient management

Growing adoption of remote patient management is accelerating demand for digital therapeutics as healthcare ecosystems shift toward virtual care delivery. Rising prevalence of chronic conditions and increased comfort with telehealth platforms strengthen momentum. Digital tools enabling real-time monitoring, medication adherence tracking, and behavioral-health interventions offer measurable clinical benefits. As providers seek scalable, cost-efficient ways to manage large patient populations, digital therapeutics become essential in supporting continuous engagement, improving treatment adherence, and enhancing long-term health outcomes.

Restraint:

Limited reimbursement in many regions

Limited reimbursement in many regions continues to constrain large-scale adoption, particularly where regulatory pathways for software-based therapies remain underdeveloped. Payers often hesitate to classify digital therapeutics as reimbursable medical interventions, slowing integration into mainstream care. Fragmented evaluation standards and insufficient clinical-economic evidence further challenge funding decisions. As a result, providers and patients frequently bear out-of-pocket costs, impeding uptake. Until reimbursement frameworks mature globally, market penetration will remain uneven across different healthcare systems.

Opportunity:

Integration with personalized treatment pathways

Integration with personalized treatment pathways presents significant expansion potential as digital therapeutics increasingly leverage AI-driven insights, behavioral analytics, and patient-specific biomarkers. Tailored treatment programs improve efficacy, enhance engagement, and reduce relapse rates across chronic, metabolic, and mental-health disorders. Growing availability of real-world evidence strengthens clinical validation, encouraging adoption within evidence-based care models. As healthcare shifts toward precision medicine, digital platforms offering individualized therapy optimization gain prominence as key enablers of patient-centric interventions.

Threat:

Data-security breaches impacting patient trust

Data-security breaches impacting patient trust remain a critical threat as digital therapeutics rely heavily on sensitive behavioral, clinical, and biometric data. Cyber vulnerabilities in cloud infrastructure, mobile applications, and API integrations can lead to exposure of personal health information, eroding user confidence. Regulatory non-compliance may result in penalties and disrupt device approvals. Heightened public scrutiny around digital privacy could slow adoption unless platforms demonstrate robust cybersecurity frameworks and transparent data-handling practices.

Covid-19 Impact:

COVID-19 significantly accelerated digital therapeutics adoption as health systems prioritized remote care models during lockdowns. Patients increasingly adopted app-based interventions, digital cognitive-behavioral tools, and chronic-disease tracking platforms to avoid in-person visits. Clinical trials shifted to virtual formats, generating greater acceptance among regulators and providers. The pandemic heightened awareness of scalable digital care pathways, and post-pandemic demand remains strong as hybrid healthcare models persist, cementing digital therapeutics' long-term role in treatment delivery.

The chronic disease management systems segment is expected to be the largest during the forecast period

The chronic disease management systems segment is expected to account for the largest market share during the forecast period, resulting from rising prevalence of diabetes, cardiovascular disorders, respiratory diseases, and lifestyle-driven conditions. These platforms deliver structured monitoring, behavioral coaching, and therapy reinforcement, improving patient self-management. Providers increasingly rely on such systems to reduce hospitalizations, optimize care coordination, and enhance treatment adherence. Their proven clinical impact and broad applicability ensure sustained dominance in the digital therapeutics landscape.

The cloud-based platforms segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cloud-based platforms segment is predicted to witness the highest growth rate, propelled by their scalability, interoperability, and seamless data integration across healthcare systems. Cloud architectures enable real-time analytics, remote access, and continuous patient engagement at lower operational costs. They support multi-device synchronization, facilitating long-term monitoring and automated therapy adjustments. As demand rises for flexible, secure, and easily deployable digital-health solutions, cloud-based platforms rapidly emerge as the fastest-expanding segment.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, attributed to expanding digital-health initiatives, rapid smartphone penetration, and increasing burden of chronic diseases. Governments across China, India, Japan, and South Korea are accelerating adoption of remote-care programs and app-based therapeutic tools. Rising healthcare digitalization, favorable telemedicine regulations, and large patient populations further drive uptake. These conditions firmly position Asia Pacific as the leading market for digital therapeutics deployment.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR associated with strong reimbursement progress, rapid integration of digital therapeutics into clinical workflows, and robust venture-capital funding. The presence of leading digital-health innovators, supportive regulatory frameworks, and expanding partnerships between providers and technology firms accelerates adoption. Growing emphasis on outcome-based care and widespread acceptance of remote therapeutic interventions reinforce North America's status as the fastest-growing regional market.

Key players in the market

Some of the key players in Digital Therapeutics Market include Pear Therapeutics, Teladoc Health, Propeller Health, Omada Health, Welldoc, Noom, Akili Interactive, Click Therapeutics, Biofourmis, Kaia Health, Livongo (Teladoc), Mahana Therapeutics, Voluntis, Happify Health, Better Therapeutics, Big Health and BehaVR.

Key Developments:

In November 2025, Noom introduced Noom Med, combining digital therapeutics with telehealth prescribing for obesity and metabolic disorders, integrating behavioral science with AI-driven personalized coaching for sustainable health outcomes.

In October 2025, Noom introduced Noom Med, combining digital therapeutics with telehealth prescribing for obesity and metabolic disorders, integrating behavioral science with AI-driven personalized coaching for sustainable health outcomes.

In September 2025, Akili Interactive expanded its FDA-cleared digital therapeutic EndeavorRx, adding gamified modules for ADHD and cognitive disorders, while advancing clinical trials for broader neurological applications.

Treatment Types Covered:

  • Behavioral Health Programs
  • Chronic Disease Management Systems
  • Physical Rehabilitation Platforms
  • Lifestyle & Nutrition Interventions
  • Neurological Therapy Programs
  • Substance Use & Addiction Therapy

Deployments Covered:

  • Cloud-Based Platforms
  • On-Premise Platforms
  • Hybrid Digital Therapy Systems
  • Subscription-Based Platforms
  • Integrated Hospital Platforms

Technologies Covered:

  • AI-Based Therapy Platforms
  • Mobile & App-Based Solutions
  • Wearable-Integrated Systems
  • Remote Monitoring Technologies
  • VR/AR Therapy Platforms
  • Data Analytics & Cloud Systems

Applications Covered:

  • Diabetes & Metabolic Disorders
  • Mental Health Disorders
  • Cardiovascular Diseases
  • Respiratory Disorders
  • Pain Management
  • Obesity & Lifestyle Disorders

End Users Covered:

  • Hospitals & Clinics
  • Employers & Corporate Wellness
  • Pharmaceutical Companies
  • Research Organizations
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Digital Therapeutics Market, By Treatment Type

  • 5.1 Introduction
  • 5.2 Behavioral Health Programs
  • 5.3 Chronic Disease Management Systems
  • 5.4 Physical Rehabilitation Platforms
  • 5.5 Lifestyle & Nutrition Interventions
  • 5.6 Neurological Therapy Programs
  • 5.7 Substance Use & Addiction Therapy

6 Global Digital Therapeutics Market, By Deployment

  • 6.1 Introduction
  • 6.2 Cloud-Based Platforms
  • 6.3 On-Premise Platforms
  • 6.4 Hybrid Digital Therapy Systems
  • 6.5 Subscription-Based Platforms
  • 6.6 Integrated Hospital Platforms

7 Global Digital Therapeutics Market, By Technology

  • 7.1 Introduction
  • 7.2 AI-Based Therapy Platforms
  • 7.3 Mobile & App-Based Solutions
  • 7.4 Wearable-Integrated Systems
  • 7.5 Remote Monitoring Technologies
  • 7.6 VR/AR Therapy Platforms
  • 7.7 Data Analytics & Cloud Systems

8 Global Digital Therapeutics Market, By Application

  • 8.1 Introduction
  • 8.2 Diabetes & Metabolic Disorders
  • 8.3 Mental Health Disorders
  • 8.4 Cardiovascular Diseases
  • 8.5 Respiratory Disorders
  • 8.6 Pain Management
  • 8.7 Obesity & Lifestyle Disorders

9 Global Digital Therapeutics Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals & Clinics
  • 9.3 Employers & Corporate Wellness
  • 9.4 Pharmaceutical Companies
  • 9.5 Research Organizations
  • 9.6 Other End Users

10 Global Digital Therapeutics Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Pear Therapeutics
  • 12.2 Teladoc Health
  • 12.3 Propeller Health
  • 12.4 Omada Health
  • 12.5 Welldoc
  • 12.6 Noom
  • 12.7 Akili Interactive
  • 12.8 Click Therapeutics
  • 12.9 Biofourmis
  • 12.10 Kaia Health
  • 12.11 Livongo (Teladoc)
  • 12.12 Mahana Therapeutics
  • 12.13 Voluntis
  • 12.14 Happify Health
  • 12.15 Better Therapeutics
  • 12.16 Big Health
  • 12.17 BehaVR

List of Tables

  • Table 1 Global Digital Therapeutics Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Digital Therapeutics Market Outlook, By Treatment Type (2024-2032) ($MN)
  • Table 3 Global Digital Therapeutics Market Outlook, By Behavioral Health Programs (2024-2032) ($MN)
  • Table 4 Global Digital Therapeutics Market Outlook, By Chronic Disease Management Systems (2024-2032) ($MN)
  • Table 5 Global Digital Therapeutics Market Outlook, By Physical Rehabilitation Platforms (2024-2032) ($MN)
  • Table 6 Global Digital Therapeutics Market Outlook, By Lifestyle & Nutrition Interventions (2024-2032) ($MN)
  • Table 7 Global Digital Therapeutics Market Outlook, By Neurological Therapy Programs (2024-2032) ($MN)
  • Table 8 Global Digital Therapeutics Market Outlook, By Substance Use & Addiction Therapy (2024-2032) ($MN)
  • Table 9 Global Digital Therapeutics Market Outlook, By Deployment (2024-2032) ($MN)
  • Table 10 Global Digital Therapeutics Market Outlook, By Cloud-Based Platforms (2024-2032) ($MN)
  • Table 11 Global Digital Therapeutics Market Outlook, By On-Premise Platforms (2024-2032) ($MN)
  • Table 12 Global Digital Therapeutics Market Outlook, By Hybrid Digital Therapy Systems (2024-2032) ($MN)
  • Table 13 Global Digital Therapeutics Market Outlook, By Subscription-Based Platforms (2024-2032) ($MN)
  • Table 14 Global Digital Therapeutics Market Outlook, By Integrated Hospital Platforms (2024-2032) ($MN)
  • Table 15 Global Digital Therapeutics Market Outlook, By Technology (2024-2032) ($MN)
  • Table 16 Global Digital Therapeutics Market Outlook, By AI-Based Therapy Platforms (2024-2032) ($MN)
  • Table 17 Global Digital Therapeutics Market Outlook, By Mobile & App-Based Solutions (2024-2032) ($MN)
  • Table 18 Global Digital Therapeutics Market Outlook, By Wearable-Integrated Systems (2024-2032) ($MN)
  • Table 19 Global Digital Therapeutics Market Outlook, By Remote Monitoring Technologies (2024-2032) ($MN)
  • Table 20 Global Digital Therapeutics Market Outlook, By VR/AR Therapy Platforms (2024-2032) ($MN)
  • Table 21 Global Digital Therapeutics Market Outlook, By Data Analytics & Cloud Systems (2024-2032) ($MN)
  • Table 22 Global Digital Therapeutics Market Outlook, By Application (2024-2032) ($MN)
  • Table 23 Global Digital Therapeutics Market Outlook, By Diabetes & Metabolic Disorders (2024-2032) ($MN)
  • Table 24 Global Digital Therapeutics Market Outlook, By Mental Health Disorders (2024-2032) ($MN)
  • Table 25 Global Digital Therapeutics Market Outlook, By Cardiovascular Diseases (2024-2032) ($MN)
  • Table 26 Global Digital Therapeutics Market Outlook, By Respiratory Disorders (2024-2032) ($MN)
  • Table 27 Global Digital Therapeutics Market Outlook, By Pain Management (2024-2032) ($MN)
  • Table 28 Global Digital Therapeutics Market Outlook, By Obesity & Lifestyle Disorders (2024-2032) ($MN)
  • Table 29 Global Digital Therapeutics Market Outlook, By End User (2024-2032) ($MN)
  • Table 30 Global Digital Therapeutics Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 31 Global Digital Therapeutics Market Outlook, By Employers & Corporate Wellness (2024-2032) ($MN)
  • Table 32 Global Digital Therapeutics Market Outlook, By Pharmaceutical Companies (2024-2032) ($MN)
  • Table 33 Global Digital Therapeutics Market Outlook, By Research Organizations (2024-2032) ($MN)
  • Table 34 Global Digital Therapeutics Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.